Peter Weeke1, Raafia Muhammad2, Jessica T Delaney2, Christian Shaffer2, Jonathan D Mosley2, Marcia Blair2, Laura Short2, Tanya Stubblefield2, Dan M Roden3, Dawood Darbar3. 1. Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark. 2. Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA. 3. Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN, USA Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, 2215B Garland Avenue, Room 1285A MRB IV, Nashville 37323-6602, TN, USA.
Abstract
AIMS: Positional cloning and candidate gene approaches have shown that atrial fibrillation (AF) is a complex disease with familial aggregation. Here, we employed whole-exome sequencing (WES) in AF kindreds to identify variants associated with familial AF. METHODS AND RESULTS: WES was performed on 18 individuals in six modestly sized familial AF kindreds. After filtering very rare variants by multiple metrics, we identified 39 very rare and potentially pathogenic variants [minor allele frequency (MAF) ≤0.04%] in genes not previously associated with AF. Despite stringent filtering >1 very rare variants in the 5/6 of the kindreds were identified, whereas no plausible variants contributing to familial AF were found in 1/6 of the kindreds. Two candidate AF variants in the calcium channel subunit genes (CACNB2 and CACNA2D4) were identified in two separate families using expression data and predicted function. CONCLUSION: By coupling family data with exome sequencing, we identified multiple very rare potentially pathogenic variants in five of six families, suggestive of a complex disease mechanism, whereas none were identified in the remaining AF pedigree. This study highlights some important limitations and challenges associated with performing WES in AF including the importance of having large well-curated multi-generational pedigrees, the issue of potential AF misclassification, and limitations of WES technology when applied to a complex disease. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Positional cloning and candidate gene approaches have shown that atrial fibrillation (AF) is a complex disease with familial aggregation. Here, we employed whole-exome sequencing (WES) in AF kindreds to identify variants associated with familial AF. METHODS AND RESULTS: WES was performed on 18 individuals in six modestly sized familial AF kindreds. After filtering very rare variants by multiple metrics, we identified 39 very rare and potentially pathogenic variants [minor allele frequency (MAF) ≤0.04%] in genes not previously associated with AF. Despite stringent filtering >1 very rare variants in the 5/6 of the kindreds were identified, whereas no plausible variants contributing to familial AF were found in 1/6 of the kindreds. Two candidate AF variants in the calcium channel subunit genes (CACNB2 and CACNA2D4) were identified in two separate families using expression data and predicted function. CONCLUSION: By coupling family data with exome sequencing, we identified multiple very rare potentially pathogenic variants in five of six families, suggestive of a complex disease mechanism, whereas none were identified in the remaining AF pedigree. This study highlights some important limitations and challenges associated with performing WES in AF including the importance of having large well-curated multi-generational pedigrees, the issue of potential AF misclassification, and limitations of WES technology when applied to a complex disease. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Charles Antzelevitch; Guido D Pollevick; Jonathan M Cordeiro; Oscar Casis; Michael C Sanguinetti; Yoshiyasu Aizawa; Alejandra Guerchicoff; Ryan Pfeiffer; Antonio Oliva; Bernd Wollnik; Philip Gelber; Elias P Bonaros; Elena Burashnikov; Yuesheng Wu; John D Sargent; Stefan Schickel; Ralf Oberheiden; Atul Bhatia; Li-Fern Hsu; Michel Haïssaguerre; Rainer Schimpf; Martin Borggrefe; Christian Wolpert Journal: Circulation Date: 2007-01-15 Impact factor: 29.690
Authors: Michael J Bamshad; Sarah B Ng; Abigail W Bigham; Holly K Tabor; Mary J Emond; Deborah A Nickerson; Jay Shendure Journal: Nat Rev Genet Date: 2011-09-27 Impact factor: 53.242
Authors: John A Vest; Xander H T Wehrens; Steven R Reiken; Stephan E Lehnart; Dobromir Dobrev; Parag Chandra; Peter Danilo; Ursula Ravens; Michael R Rosen; Andrew R Marks Journal: Circulation Date: 2005-04-26 Impact factor: 29.690
Authors: Jonathan M Cordeiro; Mark Marieb; Ryan Pfeiffer; Kirstine Calloe; Elena Burashnikov; Charles Antzelevitch Journal: J Mol Cell Cardiol Date: 2009-05 Impact factor: 5.000
Authors: Nadine Norton; Peggy D Robertson; Mark J Rieder; Stephan Züchner; Evadnie Rampersaud; Eden Martin; Duanxiang Li; Deborah A Nickerson; Ray E Hershberger Journal: Circ Cardiovasc Genet Date: 2012-02-15
Authors: Quinn S Wells; Jason R Becker; Yan R Su; Jonathan D Mosley; Peter Weeke; Laura D'Aoust; Natalie L Ausborn; Andrea H Ramirez; Jean P Pfotenhauer; Allen J Naftilan; Larry Markham; Vernat Exil; Dan M Roden; Charles C Hong Journal: Circ Cardiovasc Genet Date: 2013-07-16
Authors: Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure Journal: Nature Date: 2009-08-16 Impact factor: 49.962
Authors: Ingrid E Christophersen; Jared W Magnani; Xiaoyan Yin; John Barnard; Lu-Chen Weng; Dan E Arking; Maartje N Niemeijer; Steven A Lubitz; Christy L Avery; Qing Duan; Stephan B Felix; Joshua C Bis; Kathleen F Kerr; Aaron Isaacs; Martina Müller-Nurasyid; Christian Müller; Kari E North; Alex P Reiner; Lesley F Tinker; Jan A Kors; Alexander Teumer; Astrid Petersmann; Moritz F Sinner; Petra Buzkova; Jonathan D Smith; David R Van Wagoner; Uwe Völker; Melanie Waldenberger; Annette Peters; Thomas Meitinger; Marian C Limacher; Kirk C Wilhelmsen; Bruce M Psaty; Albert Hofman; Andre Uitterlinden; Bouwe P Krijthe; Zhu-Ming Zhang; Renate B Schnabel; Stefan Kääb; Cornelia van Duijn; Jerome I Rotter; Nona Sotoodehnia; Marcus Dörr; Yun Li; Mina K Chung; Elsayed Z Soliman; Alvaro Alonso; Eric A Whitsel; Bruno H Stricker; Emelia J Benjamin; Susan R Heckbert; Patrick T Ellinor Journal: Circ Cardiovasc Genet Date: 2017-08
Authors: Peter Weeke; Joshua C Denny; Lisa Basterache; Christian Shaffer; Erica Bowton; Christie Ingram; Dawood Darbar; Dan M Roden Journal: Circ Cardiovasc Genet Date: 2014-11-19
Authors: Bianca J J M Brundel; Xun Ai; Mellanie True Hills; Myrthe F Kuipers; Gregory Y H Lip; Natasja M S de Groot Journal: Nat Rev Dis Primers Date: 2022-04-07 Impact factor: 52.329
Authors: Daniela Husser; Laura Ueberham; Borislav Dinov; Jedrzej Kosiuk; Jelena Kornej; Gerhard Hindricks; M Benjamin Shoemaker; Dan M Roden; Andreas Bollmann; Petra Büttner Journal: Sci Rep Date: 2016-11-18 Impact factor: 4.379
Authors: Daniela Husser; Petra Büttner; Laura Ueberham; Borislav Dinov; Philipp Sommer; Arash Arya; Gerhard Hindricks; Andreas Bollmann Journal: PLoS One Date: 2016-11-21 Impact factor: 3.240
Authors: Steven A Lubitz; Jennifer A Brody; Nathan A Bihlmeyer; Carolina Roselli; Lu-Chen Weng; Ingrid E Christophersen; Alvaro Alonso; Eric Boerwinkle; Richard A Gibbs; Joshua C Bis; L Adrienne Cupples; Peter J Mohler; Deborah A Nickerson; Donna Muzny; Marco V Perez; Bruce M Psaty; Elsayed Z Soliman; Nona Sotoodehnia; Kathryn L Lunetta; Emelia J Benjamin; Susan R Heckbert; Dan E Arking; Patrick T Ellinor; Honghuang Lin Journal: PLoS Genet Date: 2016-09-02 Impact factor: 5.917